S&P 500   4,306.42 (+0.16%)
DOW   33,622.19 (-0.13%)
QQQ   360.26 (+0.63%)
AAPL   171.85 (+0.68%)
MSFT   317.88 (+1.35%)
META   305.28 (+0.43%)
GOOGL   131.95 (-0.27%)
AMZN   127.83 (+1.47%)
TSLA   252.08 (+2.31%)
NVDA   437.22 (+1.47%)
NIO   9.06 (+1.68%)
BABA   87.15 (+1.88%)
AMD   104.12 (+1.32%)
T   15.01 (+0.00%)
F   12.57 (+0.08%)
MU   68.15 (+4.52%)
CGC   0.80 (-1.19%)
GE   110.54 (-1.60%)
DIS   80.88 (+0.94%)
AMC   8.01 (+2.82%)
PFE   32.95 (+2.68%)
PYPL   58.70 (+0.89%)
NFLX   378.04 (+0.45%)
S&P 500   4,306.42 (+0.16%)
DOW   33,622.19 (-0.13%)
QQQ   360.26 (+0.63%)
AAPL   171.85 (+0.68%)
MSFT   317.88 (+1.35%)
META   305.28 (+0.43%)
GOOGL   131.95 (-0.27%)
AMZN   127.83 (+1.47%)
TSLA   252.08 (+2.31%)
NVDA   437.22 (+1.47%)
NIO   9.06 (+1.68%)
BABA   87.15 (+1.88%)
AMD   104.12 (+1.32%)
T   15.01 (+0.00%)
F   12.57 (+0.08%)
MU   68.15 (+4.52%)
CGC   0.80 (-1.19%)
GE   110.54 (-1.60%)
DIS   80.88 (+0.94%)
AMC   8.01 (+2.82%)
PFE   32.95 (+2.68%)
PYPL   58.70 (+0.89%)
NFLX   378.04 (+0.45%)
S&P 500   4,306.42 (+0.16%)
DOW   33,622.19 (-0.13%)
QQQ   360.26 (+0.63%)
AAPL   171.85 (+0.68%)
MSFT   317.88 (+1.35%)
META   305.28 (+0.43%)
GOOGL   131.95 (-0.27%)
AMZN   127.83 (+1.47%)
TSLA   252.08 (+2.31%)
NVDA   437.22 (+1.47%)
NIO   9.06 (+1.68%)
BABA   87.15 (+1.88%)
AMD   104.12 (+1.32%)
T   15.01 (+0.00%)
F   12.57 (+0.08%)
MU   68.15 (+4.52%)
CGC   0.80 (-1.19%)
GE   110.54 (-1.60%)
DIS   80.88 (+0.94%)
AMC   8.01 (+2.82%)
PFE   32.95 (+2.68%)
PYPL   58.70 (+0.89%)
NFLX   378.04 (+0.45%)
S&P 500   4,306.42 (+0.16%)
DOW   33,622.19 (-0.13%)
QQQ   360.26 (+0.63%)
AAPL   171.85 (+0.68%)
MSFT   317.88 (+1.35%)
META   305.28 (+0.43%)
GOOGL   131.95 (-0.27%)
AMZN   127.83 (+1.47%)
TSLA   252.08 (+2.31%)
NVDA   437.22 (+1.47%)
NIO   9.06 (+1.68%)
BABA   87.15 (+1.88%)
AMD   104.12 (+1.32%)
T   15.01 (+0.00%)
F   12.57 (+0.08%)
MU   68.15 (+4.52%)
CGC   0.80 (-1.19%)
GE   110.54 (-1.60%)
DIS   80.88 (+0.94%)
AMC   8.01 (+2.82%)
PFE   32.95 (+2.68%)
PYPL   58.70 (+0.89%)
NFLX   378.04 (+0.45%)
NASDAQ:CRNX

Crinetics Pharmaceuticals (CRNX) Insider Trading & Ownership

$29.34
0.00 (0.00%)
(As of 12:27 PM ET)
Compare
Today's Range
$29.11
▼
$30.17
50-Day Range
$15.97
▼
$30.59
52-Week Range
$15.23
▼
$31.00
Volume
439,443 shs
Average Volume
751,028 shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$110,300.00
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$3.08 M
Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRNX Insider Buying and Selling by Quarter


Crinetics Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2023Richard Scott StruthersCEOSell14,157$20.35$288,094.95  
7/11/2023Richard Scott StruthersCEOSell24,384$20.14$491,093.76  
6/20/2023Marc WilsonCFOSell30,922$19.97$617,512.34  
6/16/2023Richard Scott StruthersCEOSell50,000$20.81$1,040,500.00  
6/8/2023Coelho Rogerio VivaldiDirectorBuy5,000$22.06$110,300.00  
4/5/2023Dana PizzutiInsiderSell8,212$16.15$132,623.80  
1/25/2023Stephen F BetzInsiderSell8,336$21.07$175,639.52  
1/17/2023Stephen F BetzInsiderSell3,126$18.00$56,268.00  
12/15/2022Stephen F BetzInsiderSell3,126$16.00$50,016.00  
12/1/2022Stephen F BetzInsiderSell3,126$17.84$55,767.84  
11/15/2022Stephen F BetzInsiderSell3,126$18.72$58,518.72  
10/17/2022Stephen F BetzInsiderSell3,126$17.73$55,423.98  
10/3/2022Stephen F BetzInsiderSell3,126$19.64$61,394.64  
(Data available from 1/1/2013 forward)












CRNX Insider Trading Activity - Frequently Asked Questions

Who is on Crinetics Pharmaceuticals's Insider Roster?

The list of insiders at Crinetics Pharmaceuticals includes Ajay Madan, Coelho Rogerio Vivaldi, Dana Pizzuti, Jeff E Knight, Marc Wilson, Matthew K Fust, Perceptive Advisors Llc, Richard Scott Struthers, and Stephen F Betz. Learn more on insiders at CRNX.

What percentage of Crinetics Pharmaceuticals stock is owned by insiders?

7.00% of Crinetics Pharmaceuticals stock is owned by insiders. Learn more on CRNX's insider holdings.

Which Crinetics Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased CRNX shares in the last 24 months: Coelho Rogerio Vivaldi ($110,300.00), and Perceptive Advisors Llc ($27,259,983.30).

How much insider buying is happening at Crinetics Pharmaceuticals?

Insiders have purchased a total of 1,362,515 CRNX shares in the last 24 months for a total of $27,370,283.30 bought.

Which Crinetics Pharmaceuticals insiders have been selling company stock?

The following insiders have sold CRNX shares in the last 24 months: Ajay Madan ($239,118.13), Dana Pizzuti ($132,623.80), Jeff E Knight ($23,846.40), Marc Wilson ($617,512.34), Matthew K Fust ($347,799.00), Richard Scott Struthers ($6,080,666.78), and Stephen F Betz ($2,628,944.08).

How much insider selling is happening at Crinetics Pharmaceuticals?

Insiders have sold a total of 429,397 Crinetics Pharmaceuticals shares in the last 24 months for a total of $10,070,510.53 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:CRNX) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -